Vstm stock earnings
(NASDAQ: VSTM) is a commercial biopharmaceutical company that develops new medicines to improve the lives of patients diagnosed with cancer. Verastem Verastem, Inc. (NASDAQ: VSTM) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Earnings Estimates - Current Qtr 03/31/20. See More. Average Estimate -0.19; Number of Estimates 1; High Estimate ©2020 StockTwits, Inc. All rights reserved. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed
5 Mar 2020 Analysts estimates state that Verastem, Inc. [VSTM] stock could reach median Verastem, Inc. [NASDAQ:VSTM]: Analyst Rating and Earnings.
Verastem Inc Forecasted to Earn FY2019 Earnings of ($1.89 ... Verastem Inc (NASDAQ:VSTM) – Stock analysts at Cantor Fitzgerald issued their FY2019 earnings per share estimates for shares of Verastem in a research note issued to investors on Thursday, March 5th. Cantor Fitzgerald analyst A. Young forecasts that the biopharmaceutical company will post earnings of ($1.89) per share for the year. Cantor Fitzgerald has a […] VSTM - Verastem Stock Price - Barchart.com As of late, it has definitely been a great time to be an investor in Verastem, Inc. (VSTM). VSTM: 2.56 Momentum Market Performance Top 100 Stocks Today's Price Surprises New Highs & Lows Economic Overview Earnings Within 7 Days Earnings & Dividends Stock Screener. Barchart Trade Picks. Today's Top Stock Pick All Top Stock Picks. Verastem Inc Stock Quote: VSTM Stock News, Quotes ...
Verastem Inc (NASDAQ:VSTM) – Stock analysts at Cantor Fitzgerald issued their FY2019 earnings per share estimates for shares of Verastem in a research note issued to investors on Thursday, March 5th. Cantor Fitzgerald analyst A. Young forecasts that the biopharmaceutical company will post earnings of ($1.89) per share for the year. Cantor Fitzgerald has a […]
Verastem, Inc. Common Stock (VSTM) Earnings Report Date ...
5 Mar 2020 Analysts estimates state that Verastem, Inc. [VSTM] stock could reach median Verastem, Inc. [NASDAQ:VSTM]: Analyst Rating and Earnings.
Earnings announcement* for VSTM: May 14, 2020. 30 Mar 2020 Verastem, Inc. (VSTM) latest earnings report: revenue, EPS, surprise, history, news and analysis. Earnings. Verastem (NASDAQ:VSTM) Earnings Information. Verastem last announced its quarterly earnings data on March 11th, 2020. The biopharmaceutical Find the latest and the upcoming Verastem earnings report Apr 5, 2020 as well The TipRanks Smart Score analyzes stocks based on 8 factors extracted from This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the
VSTM | Verastem Inc. Analyst Estimates | MarketWatch
As of late, it has definitely been a great time to be an investor in Verastem, Inc. (VSTM). VSTM: 2.56 Momentum Market Performance Top 100 Stocks Today's Price Surprises New Highs & Lows Economic Overview Earnings Within 7 Days Earnings & Dividends Stock Screener. Barchart Trade Picks. Today's Top Stock Pick All Top Stock Picks. Verastem Inc Stock Quote: VSTM Stock News, Quotes ... Oct 30, 2019 · VSTM, Verastem Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines VSTM Stock Rating and Data | Verastem - GuruFocus.com
©2020 StockTwits, Inc. All rights reserved. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed Verastem stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. VSTM Stock Summary. VSTM's price/sales ratio is 18.53; that's higher than the P/ S ratio of 94.45% of US stocks. In terms of twelve month growth in earnings